# Relationship between trace elements status and atrial fibrillation in patients with valvular heart diseases

**Authors:** Xiang Liu, Yijia Shao, Zirui Huang, Jiayin Huang, Linjiang Han, Shaoyou Lu, Haijiang Guo, Jian Liu

PMC · DOI: 10.3389/fcvm.2025.1691845 · Frontiers in Cardiovascular Medicine · 2025-11-07

## TL;DR

This study finds that trace elements like copper and strontium are linked to atrial fibrillation in patients with valvular heart disease.

## Contribution

The study is the first to investigate trace element status in patients with valvular heart disease and atrial fibrillation.

## Key findings

- VHDAF patients had higher levels of copper and mercury, and lower levels of strontium compared to VHD patients.
- A mixture of 12 trace elements was significantly associated with AF in patients with valvular heart disease.
- Copper and mercury showed positive effects, while strontium and lithium showed negative effects on AF risk.

## Abstract

Atrial fibrillation (AF) combined with valvular heart disease (VHD) is increasingly prevalent worldwide and is associated with high morbidity and mortality. Studies have showed trace element concentrations varied in patients with AF and may be involved in the pathogenesis of AF. However, no data is currently available for those with VHD.

Urine samples as well as clinical data were collected from 72 VHD patients with AF (VHDAF) and 72 VHD patients without AF (VHD) and further analyzed for a panel of trace elements: lithium, manganese, cobalt, copper, zinc, arsenic, selenium, strontium, Cadmium, mercury, thallium, lead. Quantile g-computation was adopted to explore the joint effect of the 12 trace elements on AF in this population, and internal validation was performed using 1,000 bootstrap re-samples.

Compared with the VHD group, Sr levels were reduced, while Mn, Cu and Hg concentrations were increased in the VHDAF group. Quantile g-computation model indicated a significant association between the mixtures of the 12 urinary trace elements and AF in patients with heart valve disease (adjusted OR: 2.051; 95% CI: 1.180–3.565; p = 0.011). Positive partial effect was owing to Cu (weight: 0.43) and Hg (weight: 0.18), while negative partial effect mainly attributed to Sr (weight: 0.43) and Li (weight: 0.23).

VHDAF patients had higher Cu levels and lower Sr levels, and the two elements have been supposed to exert the largest influence on AF. Further research is needed to establish the causal relationships.

## Linked entities

- **Chemicals:** lithium (PubChem CID 28486), manganese (PubChem CID 23930), cobalt (PubChem CID 104730), copper (PubChem CID 23978), zinc (PubChem CID 23994), arsenic (PubChem CID 5359596), selenium (PubChem CID 6326970), strontium (PubChem CID 5359327), Cadmium (PubChem CID 23973), mercury (PubChem CID 23931), thallium (PubChem CID 5359464), lead (PubChem CID 5352425)
- **Diseases:** atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Diseases:** AF (MESH:D001281), VHD (MESH:D006349)
- **Chemicals:** thallium (MESH:D013793), Hg (MESH:D008628), Cadmium (MESH:D002104), selenium (MESH:D012643), zinc (MESH:D015032), lead (MESH:D007854), Cu (MESH:D003300), cobalt (MESH:D003035), Li (MESH:D008094), Sr (MESH:D013324), arsenic (MESH:D001151), Mn (MESH:D008345)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12634502/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12634502/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12634502/full.md

---
Source: https://tomesphere.com/paper/PMC12634502